Hepamerz%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252528l-Ornithine%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520l-Aspartate%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520-%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520lola%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252529

# Hepamerz (L-Ornithine L-Aspartate) ## Overview Hepamerz is a combination of the amino acids L-ornithine and L-aspartate. It is believed to promote ammonia detoxification in the liver by stimulating the urea cycle and glutamine synthesis. ## Primary Indications * Treatment of hyperammonemia associated with liver diseases such as cirrhosis. ## Adult Dosing * **Oral:** Typically 3 to 6 grams (equivalent to one to two sachets of 3g each) three times daily, depending on the severity of hyperammonemia and patient tolerance. * **Intravenous:** Typically 5 grams administered as an infusion over 30 minutes, up to twice daily. The exact intravenous regimen may vary based on clinical assessment and local protocols. ## Pediatric Dosing * Pediatric dosing is not well-established and should be determined by a specialist based on individual patient factors and clinical response. ## Dose Adjustments * No specific dose adjustments are typically required for renal or hepatic impairment, as the drug is metabolized and excreted by the liver and kidneys. However, caution is advised in patients with severe renal impairment due to potential accumulation. ## Contraindications * Known hypersensitivity to L-ornithine or L-aspartate. * Severe kidney disease. ## Adverse Effects * Gastrointestinal disturbances: Nausea, vomiting, abdominal discomfort, diarrhea. * Rarely: Allergic reactions. ## Key Drug Interactions * No significant drug interactions have been widely reported. ## Monitoring * Monitor ammonia levels. * Assess for signs and symptoms of hyperammonemia and hepatic encephalopathy. * Monitor for gastrointestinal side effects. ## Clinical Pearls * The oral formulation can be mixed with water, juice, or other liquids. * Hepamerz is not a substitute for managing the underlying liver disease. * Its efficacy in non-liver-related hyperammonemia is not established. *** *Please verify current prescribing information and consult with a healthcare professional before making any treatment decisions.*